Normal circulating adult human red blood cells contain inactive NOS proteins.

Human red blood cells (RBCs) are considered to play a significant role in both blood pressure (BP) regulation and tissue oxygenation, because they can bind as well as release previously bound nitric oxide (NO) from hemoglobin (Hb) and other intracellular components. Two reports indicate that the human RBC possesses nitric oxide synthase (NOS) activity-by the accumulation of nitrite across a membraned chamber in one and by the hydrolysis of labeled L-arginine, presumably to labeled L-citrulline, in the other. Furthermore, NOS proteins have been identified by immunoblot in RBCs. If true, the presence of NOS activity would convert the human RBC to a donor with limited ability to bind exogenously generated NO. In considering the importance of the question of the presence or not of NO synthetic capacity of this cell in BP regulation and tissue perfusion, whether human RBCs are, indeed, able to hydrolyze L-arginine to L-citrulline, the coproduct of NO was explored. RBC samples collected from control subjects were assayed for NOS activity by incubation of homogenized cellular fractions with labeled tritiated L-arginine in the presence of 0.5 mmol/L NADPH. By this method, the amino acid coproduct of NO, tritiated L-citrulline, would be recovered in the supernatant after removal of unused substrate by cationic resin treatment. At first, activity appeared to be present in the RBC supernatant but not in the pellet. However, activity was not suppressed by known inhibitors of NOS, whereas activity was suppressed by norvaline, an inhibitor of arginase activity with no known effect on NOS. By contrast, RBC arginase activity was not inhibited by N(omega)-nitro-L-arginine, NG-methyl-L-arginine, or aminoguanidine, known inhibitors of NOS, but was inhibited by norvaline. The label recovered by thin-layer chromatography was determined not to be tritiated L-citrulline but was instead tritiated L-ornithine, the product of arginase activity. Thus the enzymatic hydrolysis of L-arginine was not caused by NOS but was a result of the action of the enzyme arginase, which abounds in this cell. However, proteins interacting with antibodies to the endothelial and inducible isoforms of NOS were detected in human RBCs by immunoblot. Together, these findings indicate that human RBCs collected from normal adult individuals possess proteins that react with monoclonal antibodies to the Inducible and endothelial isoforms of NOS, but the proteins are without catalytic activity.

[1]  R. Gopalakrishna,et al.  Separation and estimation of arginine-related metabolites in tissues. , 1980, Analytical biochemistry.

[2]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[3]  H. Ginsburg,et al.  Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor , 1995, The Journal of experimental medicine.

[4]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[5]  J. Gogas,et al.  Nitric oxide and peroxynitrite production by human erythrocytes: a causative factor of toxic anemia in breast cancer patients. , 1995, Anticancer research.

[6]  J. Stamler,et al.  S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control , 1996, Nature.

[7]  R. Rognstad Sources of ammonia for urea synthesis in isolated rat liver cells. , 1977, Biochimica et biophysica acta.

[8]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[9]  A. Nussler,et al.  Inflammation, immunoregulation, and inducible nitric oxide synthase , 1993, Journal of leukocyte biology.

[10]  J S Beckman,et al.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. , 1992, Archives of biochemistry and biophysics.

[11]  T. Saheki,et al.  Regulation of urea synthesis in rat liver. Inhibition of urea synthesis by L-norvaline. , 1979, Journal of biochemistry.

[12]  B. Kalyanaraman,et al.  The role of glutathione in the transport and catabolism of nitric oxide , 1996, FEBS letters.

[13]  S. Snyder,et al.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[15]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  A. Caruso,et al.  Ornithine Decarboxylase Activity and Polyamines level from red Cells Lysate of Uraemic Patients and Normal Healthy Subjects , 1987, The International journal of artificial organs.

[18]  J. Stamler,et al.  The oxyhemoglobin reaction of nitric oxide. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Ignarro Signal transduction mechanisms involving nitric oxide. , 1991, Biochemical pharmacology.

[20]  E. Kang,et al.  Upregulation of nitric oxide synthase in cultured human keratinocytes after ultraviolet B and bradykinin , 1996, Photodermatology, photoimmunology & photomedicine.

[21]  I. T. Demchenko,et al.  Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. , 1997, Science.

[22]  T. Billiar,et al.  New insights into the regulation of inducible nitric oxide synthesis. , 1994, The American journal of physiology.

[23]  J. Mehta,et al.  Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. , 1998, Journal of cardiovascular pharmacology.

[24]  S. Brusilow Urea cycle enzymes , 2001 .

[25]  M. Feelisch,et al.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. , 1987, European journal of pharmacology.

[26]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[27]  A. Hunter,et al.  THE INHIBITION OF ARGINASE BY AMINO ACIDS , 1945 .

[28]  J. Liao,et al.  Arginase modulates nitric oxide production in activated macrophages. , 1998, American journal of physiology. Heart and circulatory physiology.

[29]  B. Jubelin,et al.  Erythrocytes may synthesize their own nitric oxide. , 1996, American journal of hypertension.